Literature DB >> 21326920

The bacterial virulence factor NleA's involvement in intestinal tight junction disruption during enteropathogenic E. coli infection is independent of its putative PDZ binding domain.

Ajitha Thanabalasuriar1, Athanasia Koutsouris, Gail Hecht, Samantha Gruenheid.   

Abstract

Enteropathogenic Escherichia coli (EPEC) is an enteric pathogen able to cause severe diarrhea. Once adhered to the small intestine, EPEC disrupts tight junctions that are important for intestinal barrier function. This disruption is dependent on the bacterial type III secretion system, as well as the translocated effectors EspF and Map. Recently we have shown that a third type III translocated bacterial effector protein, NleA, is also involved in tight junction disruption during EPEC infection. NleA has a predicted PDZ-binding domain at its C-terminus which is proposed to be involved in protein interactions with PDZ domain containing proteins. Since several PDZ-domain-containing proteins localize to tight junctions, we hypothesized that the PDZ-binding domain of NleA might be important for its role in tight junction disruption. However, here we show that a molecular variant of NleA lacking the PDZ-binding domain behaves indistinguishably from the wild-type protein with respect to disruption of tight junctions.

Entities:  

Year:  2010        PMID: 21326920      PMCID: PMC3023590          DOI: 10.4161/gmic.1.2.11685

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  25 in total

1.  Translocated EspF protein from enteropathogenic Escherichia coli disrupts host intestinal barrier function.

Authors:  B P McNamara; A Koutsouris; C B O'Connell; J P Nougayréde; M S Donnenberg; G Hecht
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions.

Authors:  I Simonovic; J Rosenberg; A Koutsouris; G Hecht
Journal:  Cell Microbiol       Date:  2000-08       Impact factor: 3.715

Review 3.  Microbial pathogenesis and cytoskeletal function.

Authors:  Samantha Gruenheid; B Brett Finlay
Journal:  Nature       Date:  2003-04-17       Impact factor: 49.962

Review 4.  Assembly of cell regulatory systems through protein interaction domains.

Authors:  Tony Pawson; Piers Nash
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

5.  Disruption of cell polarity by enteropathogenic Escherichia coli enables basolateral membrane proteins to migrate apically and to potentiate physiological consequences.

Authors:  Michelle M Muza-Moons; Athanasia Koutsouris; Gail Hecht
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

6.  Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein.

Authors:  Paul Dean; Brendan Kenny
Journal:  Mol Microbiol       Date:  2004-11       Impact factor: 3.501

7.  Virulence is positively selected by transmission success between mammalian hosts.

Authors:  Mark E Wickham; Nat F Brown; Erin C Boyle; Brian K Coombes; B Brett Finlay
Journal:  Curr Biol       Date:  2007-04-19       Impact factor: 10.834

8.  Enteropathogenic Escherichia coli activates ezrin, which participates in disruption of tight junction barrier function.

Authors:  I Simonovic; M Arpin; A Koutsouris; H J Falk-Krzesinski; G Hecht
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

9.  Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains.

Authors:  Brian K Coombes; Mark E Wickham; Mariola Mascarenhas; Samantha Gruenheid; B Brett Finlay; Mohamed A Karmali
Journal:  Appl Environ Microbiol       Date:  2008-02-01       Impact factor: 4.792

10.  Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection.

Authors:  Rosanna Mundy; Liljana Petrovska; Katherine Smollett; Nandi Simpson; Rebecca K Wilson; Jun Yu; Xuanlin Tu; Ilan Rosenshine; Simon Clare; Gordon Dougan; Gad Frankel
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

View more
  4 in total

Review 1.  Pathogenesis of human enterovirulent bacteria: lessons from cultured, fully differentiated human colon cancer cell lines.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Microbiol Mol Biol Rev       Date:  2013-09       Impact factor: 11.056

Review 2.  Effector triggered manipulation of host immune response elicited by different pathotypes of Escherichia coli.

Authors:  Elamparithi Jayamani; Eleftherios Mylonakis
Journal:  Virulence       Date:  2014       Impact factor: 5.882

Review 3.  Tight Junction Disruption Induced by Type 3 Secretion System Effectors Injected by Enteropathogenic and Enterohemorrhagic Escherichia coli.

Authors:  Paul Ugalde-Silva; Octavio Gonzalez-Lugo; Fernando Navarro-Garcia
Journal:  Front Cell Infect Microbiol       Date:  2016-08-24       Impact factor: 5.293

Review 4.  Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes.

Authors:  Fernando Navarro-Garcia; Antonio Serapio-Palacios; Paul Ugalde-Silva; Gabriela Tapia-Pastrana; Lucia Chavez-Dueñas
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.